SBFMSunshine Biopharma, Inc

Nasdaq sunshinebiopharma.com


$ 0.41 $ -0.02 (-5.09 %)    

Friday, 28-Jun-2024 15:59:17 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 0.4175
$ 0.46
$ 0.00 x 0
$ 0.42 x 1,200
$ 0.41 - $ 0.46
$ 0.28 - $ 64.50
1,550,802
na
267,747
$ -179.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-20-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 04-04-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 03-21-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-19-2020 06-30-2020 10-Q
17 05-18-2020 03-31-2020 10-Q
18 05-01-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-15-2019 06-30-2019 10-Q
21 05-20-2019 03-31-2019 10-Q
22 04-12-2019 12-31-2018 10-K
23 11-16-2018 09-30-2018 10-Q
24 08-17-2018 06-30-2018 10-Q
25 05-22-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-15-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 04-17-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-16-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-25-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-11-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 watching-sunshine-biopharma-traders-circulate-texas-congressman-roger-williams-has-disclosed-a-purchase-in-the-co

https://www.capitoltrades.com/trades/20003774100

 sunshine-biopharma-got-nasdaq-letter-that-based-on-review-of-cos-public-filings-supporting-materials-submitted-determined-to-delist-cos-securities

- SEC Filing

 sunshine-biopharma-q1-eps-200-misses-104-estimate-sales-754m-beat-700m-estimate

Sunshine Biopharma (NASDAQ:SBFM) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of ...

 sunshine-biopharma-says-as-a-result-of-borgers-settlement-with-sec-company-has-dismissed-borgers-as-its-independent-accountant

- Reuters